allogeneic tumor cell vaccine
Vaccineexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 1991 (NCT00002475)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- allogeneic tumor cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00814892 | Phase 2 | Jan 1, 2009 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT00656123 | Phase 1 | Mar 1, 2008 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00162513 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2006 | Hebrew University |
| NCT00002773 | Phase 2 | May 1, 1996 | St. Vincent Medical Center - Los Angeles |
| NCT00002475 | Phase 2 | Apr 1, 1991 | St. Vincent Medical Center - Los Angeles |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 2 | 2008 |
| St. Vincent Medical Center - Los Angeles | Academic/Hospital | 2 | 2 | 1 | 1991 |
| Hebrew University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2009 |
5 organizations
Page 1 / 1